Audeara Ltd. (AU:AUA)
ASX:AUA
Top Page
Audeara Ltd.
(Sydney:AUA)
Select Model
Select Model
Rating:44Neutral
Price Target:
AU$0.06
▼(-1.67% Downside)
Action:ReiteratedDate:02/19/26
The score is held back primarily by weak financial performance (declining revenue, persistent losses, and negative operating/free cash flow). Technicals are mixed with neutral-to-weak near-term momentum despite being above longer-term moving averages, while valuation remains unattractive due to negative earnings and no provided dividend yield.
Positive Factors
Enterprise recurring revenue model
Audeara’s core model—enterprise contracts and workplace hearing programs—creates recurring, contract-driven revenue and client stickiness. This structural channel supports predictable program fees, cross-sell of products and services, and scalable remote delivery, aiding multi-quarter revenue visibility.
Negative Factors
Declining revenue and negative margins
A recent revenue decline combined with persistent negative EBIT and net margins indicates the business is not yet achieving sustainable top-line traction. Without reversing declines, margins remain pressured, making it difficult to fund operations internally or demonstrate structural profitability over coming quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Enterprise recurring revenue model
Audeara’s core model—enterprise contracts and workplace hearing programs—creates recurring, contract-driven revenue and client stickiness. This structural channel supports predictable program fees, cross-sell of products and services, and scalable remote delivery, aiding multi-quarter revenue visibility.
Read all positive factors
Audeara Ltd. (AUA) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$11.03M
Dividend YieldN/A
Average Volume (3M)183.49K
Price to Earnings (P/E)―
Beta (1Y)0.12
Revenue Growth18.86%
EPS Growth-14.41%
CountryAU
EmployeesN/A
SectorTechnology
Sector Strength88
IndustryConsumer Electronics
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding180,889,140
10 Day Avg. Volume498,101
30 Day Avg. Volume183,491
Financial Highlights & Ratios
PEG Ratio1.17
Price to Book (P/B)2.91
Price to Sales (P/S)0.99
P/FCF Ratio-1.93
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Audeara Ltd. Business Overview & Revenue Model
Company Description
Audeara Limited, a hearing health technology company, engages in the development and sale of personalized listening products in Australia and North America. It provides A01 and A-02 Bluetooth headphones; A-02 TV bundles; and BT01 wireless transc...
How the Company Makes Money
Audeara makes money primarily by selling hearing health solutions and services, with revenue typically generated through (1) contracts/programs with organisations that require workforce hearing assessment and hearing conservation (e.g., screening,...
Audeara Ltd. Financial Statement Overview
Summary
Income Statement
35
Negative
Balance Sheet
45
Neutral
Cash Flow
40
Negative
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.94M | 3.79M | 3.19M | 2.91M | 2.07M | 1.12M |
| Gross Profit | 452.03K | 1.36M | 943.12K | 1.14M | 946.11K | 510.33K |
| EBITDA | -2.24M | -2.90M | -2.75M | -3.80M | -3.07M | -1.08M |
| Net Income | -1.00M | -1.79M | -1.60M | -3.74M | -2.95M | -1.25M |
Balance Sheet | ||||||
| Total Assets | 3.75M | 4.30M | 4.89M | 4.73M | 5.49M | 6.57M |
| Cash, Cash Equivalents and Short-Term Investments | 755.32K | 1.42M | 1.27M | 2.62M | 2.87M | 5.74M |
| Total Debt | 521.46K | 1.12M | 112.18K | 210.74K | 275.11K | 67.60K |
| Total Liabilities | 2.88M | 3.01M | 3.28M | 1.57M | 1.41M | 665.76K |
| Stockholders Equity | 871.52K | 1.29M | 1.61M | 3.17M | 4.08M | 5.91M |
Cash Flow | ||||||
| Free Cash Flow | -1.06M | -1.95M | -1.34M | -2.98M | -3.78M | -1.11M |
| Operating Cash Flow | -914.91K | -1.81M | -1.33M | -2.97M | -3.58M | -1.08M |
| Investing Cash Flow | -157.56K | -149.02K | -8.47K | -16.00K | -229.26K | -23.71K |
| Financing Cash Flow | 104.26K | 2.08M | -10.88K | 2.74M | 939.73K | 7.10M |
Audeara Ltd. Technical Analysis
Negative
0.06
Price Trends
0.07
Negative
0.06
Negative
0.04
Positive
Market Momentum
>-0.01
Positive
39.68
Neutral
59.26
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:AUA, the sentiment is Negative. The current price of 0.06 is below the 20-day moving average (MA) of 0.07, below the 50-day MA of 0.07, and above the 200-day MA of 0.04, indicating a neutral trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 39.68 is Neutral, neither overbought nor oversold. The STOCH value of 59.26 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:AUA.
Audeara Ltd. Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
50 Neutral | AU$16.85M | 0.92 | 26.81% | ― | -21.60% | -657.00% | |
44 Neutral | AU$11.03M | -4.70 | -92.37% | ― | 18.86% | -14.41% | |
41 Neutral | AU$6.32M | -0.53 | 209.30% | ― | -51.64% | -21.74% | |
39 Underperform | AU$16.49M | -2.22 | -432.52% | ― | 8.64% | 33.88% |
* Technology Sector Average
AU:AUA
Audeara Ltd.
0.06
0.03
96.77%
AU:DWG
IXUP Ltd.
0.16
-0.03
-15.79%
AU:X2M
X2M Connect Limited
0.01
-0.01
-50.00%
AU:BCC
Beam Communications Holdings Limited
0.20
0.12
150.00%
Audeara Ltd. Corporate Events
Audeara expands Auracast platform with new Clinico deals and BT-03 rollout
Mar 8, 2026
Audeara has secured purchase orders from Taiwan-based Clinico Inc., initiating three new white-label commercial programs that will see Auracast-enabled devices, packaging, accessories and a programming tool sold under the Clinico brand. The initia...
Audeara lifts revenue and narrows loss but faces going-concern uncertainty
Feb 25, 2026
Audeara Limited reported a 63.76% increase in revenue to $2.95 million for the half year to 31 December 2025, while halving its loss from ordinary activities after tax to $593,443 compared with the prior corresponding period. The company’s c...
Audeara Delivers Strong Q2 Growth as Asia-Pacific Deals Drive Hearing Tech Expansion
Jan 20, 2026
Audeara reported Q2 FY26 unaudited group revenue of $1.43 million, flat on the prior quarter but 274% higher than the same period a year earlier, supported by strong wholesale and technology licensing sales. Combined Q1 and Q2 FY26 revenues, toget...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.